Literature DB >> 17141211

Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanism.

Lisa S Middleton1, Subbu Apparsundaram, Kelley A King-Pospisil, Linda P Dwoskin.   

Abstract

In previous in vivo voltammetry studies, acute nicotine administration increased striatal dopamine clearance. The current study aimed to determine whether nicotine also increases [(3)H]dopamine uptake across the time course of the previous voltammetry studies and whether dopamine transporter trafficking to the cell surface mediates the nicotine-induced augmentation of dopamine clearance in striatum. Rats were administered nicotine (0.32 mg/kg, s.c.); striatal synaptosomes were obtained 5, 10, 40 or 60 min later. Nicotine increased (25%) the V(max) of [(3)H]dopamine uptake at 10 and 40 min. To determine whether the increase in V(max) was due to an increase in dopamine transporter density, [(3)H]GBR 12935 (1-(2-[bis(4-fluorophenyl)methoxy]ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride) binding was performed using rat striatal membranes; no differences were found between nicotine and saline-control groups at 5, 10 or 40 min post-injection, indicating that nicotine did not increase striatal dopamine transporter density; however, [(3)H]GBR 12935 binding assays determine both cell surface and intracellular dopamine transporter. Changes in cellular dopamine transporter localization in striatum were determined using biotinylation and subfractionation approaches; no differences between nicotine and saline-control groups were observed at 10 and 40 min post-injection. These results suggest that the nicotine-induced increase in dopamine uptake and clearance in striatum may occur via a trafficking-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141211      PMCID: PMC1920186          DOI: 10.1016/j.ejphar.2006.09.074

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  59 in total

1.  Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins.

Authors:  S Ramamoorthy; H E Melikian; Y Qian; R D Blakely
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

2.  Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.

Authors:  F E Pontieri; G Tanda; F Orzi; G Di Chiara
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

3.  Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.

Authors:  R A Vaughan; R A Huff; G R Uhl; M J Kuhar
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

4.  Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices.

Authors:  S A Kaiser; L Soliakov; S C Harvey; C W Luetje; S Wonnacott
Journal:  J Neurochem       Date:  1998-03       Impact factor: 5.372

5.  The organization of the endoplasmic reticulum and the intermediate compartment in cultured rat hippocampal neurons.

Authors:  J Krijnse-Locker; R G Parton; S D Fuller; G Griffiths; C G Dotti
Journal:  Mol Biol Cell       Date:  1995-10       Impact factor: 4.138

6.  Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.

Authors:  H E Melikian; S Ramamoorthy; C G Tate; R D Blakely
Journal:  Mol Pharmacol       Date:  1996-08       Impact factor: 4.436

7.  Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.

Authors:  Z B Pristupa; F McConkey; F Liu; H Y Man; F J Lee; Y T Wang; H B Niznik
Journal:  Synapse       Date:  1998-09       Impact factor: 2.562

8.  Nicotine-evoked nitric oxide release in the rat hippocampal slice.

Authors:  D A Smith; A F Hoffman; D J David; C E Adams; G A Gerhardt
Journal:  Neurosci Lett       Date:  1998-10-23       Impact factor: 3.046

9.  Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.

Authors:  S Apparsundaram; S Schroeter; E Giovanetti; R D Blakely
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

10.  Nicotine effects on dopamine clearance in rat nucleus accumbens.

Authors:  C Hart; C Ksir
Journal:  J Neurochem       Date:  1996-01       Impact factor: 5.372

View more
  13 in total

1.  Interactions between insulin and diet on striatal dopamine uptake kinetics in rodent brain slices.

Authors:  Jyoti C Patel; Melissa A Stouffer; Maria Mancini; Charles Nicholson; Kenneth D Carr; Margaret E Rice
Journal:  Eur J Neurosci       Date:  2018-08-01       Impact factor: 3.386

Review 2.  Trafficking of dopamine transporters in psychostimulant actions.

Authors:  Nancy R Zahniser; Alexander Sorkin
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

Review 3.  Pharmacogenetics of nicotine addiction: role of dopamine.

Authors:  Aryeh I Herman; Elise E DeVito; Kevin P Jensen; Mehmet Sofuoglu
Journal:  Pharmacogenomics       Date:  2014-02       Impact factor: 2.533

4.  Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner.

Authors:  Hugo A Tejeda; Luis A Natividad; James E Orfila; Oscar V Torres; Laura E O'Dell
Journal:  Psychopharmacology (Berl)       Date:  2012-06-04       Impact factor: 4.530

5.  Nicotine and amphetamine acutely cross-potentiate their behavioral and neurochemical responses in female Holtzman rats.

Authors:  Emily M Jutkiewicz; Danielle M Nicolazzo; Myung N Kim; Margaret E Gnegy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-20       Impact factor: 4.530

6.  Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.

Authors:  Bruce H Mandt; Nancy R Zahniser
Journal:  Neuropharmacology       Date:  2009-12-04       Impact factor: 5.250

7.  Nicotinic receptor activation increases [3H]dopamine uptake and cell surface expression of dopamine transporters in rat prefrontal cortex.

Authors:  Jun Zhu; Subbu Apparsundaram; Linda P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  2008-12-16       Impact factor: 4.030

8.  Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.

Authors:  E Decamp; J S Schneider
Journal:  Brain Res       Date:  2009-02-07       Impact factor: 3.252

9.  HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.

Authors:  Jun Zhu; Yaxia Yuan; Narasimha M Midde; Adrian M Gomez; Wei-Lun Sun; Pamela M Quizon; Chang-Guo Zhan
Journal:  J Neurovirol       Date:  2015-10-26       Impact factor: 2.643

10.  The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.

Authors:  Shafiqur Rahman; Nichole M Neugebauer; Zhenfa Zhang; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  Eur J Pharmacol       Date:  2008-10-26       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.